Nicholas Piramal has signed an MoU with a French pharma company to manufacture an anti-chikungunya drug.
About 90 per cent of residents of Reunion Islands, which is a French territory near Madagascar in the Indian Ocean, suffer from chikungunya, Swati Piramal, director of Nicholas Piramal, said on the sidelines of a pharma conference.
As India also